Press release

Advanced Intelligence in Veeva Commercial Cloud to Transform Customer Engagement

Sponsored by Businesswire

2019 Veeva Commercial & Medical Summit — Veeva
(NYSE:VEEV) today announced new capabilities in Veeva
Commercial Cloud
to accelerate the industry’s move to intelligent
customer engagement. With the availability of its new artificial
intelligence (AI) application, Veeva
, and embedded intelligence in Veeva
and Veeva
Vault PromoMats
, Veeva is delivering sophisticated AI-driven
applications so companies can engage more efficiently and effectively
with customers.

Veeva Commercial Cloud unifies customer engagement with multichannel
Veeva CRM
; the right content and customer data with Veeva Vault
PromoMats and Veeva
; a next-generation commercial data warehouse with Veeva
; and artificial intelligence with Veeva Andi.

“We are committed to helping the industry drive the most efficient and
effective customer engagement with the right commercial foundation
powered by AI,” said Paul Shawah, senior vice president of commercial
strategy at Veeva. “Veeva Commercial Cloud helps companies advance their
commercial strategies and drive smarter, compliant interactions with the
right customers in the right channels.”

Intelligent capabilities and solutions now part of Veeva Commercial
Cloud will help advance the industry’s progress toward intelligent
customer engagement:

  • Veeva Andi is a new AI application that embeds tailored
    insights and suggestions right in Veeva CRM. As part of the Veeva
    CRM Suite
    , Veeva Andi makes it easy to adopt, deploy, and scale
    AI. With the unique ability to control and manage AI, companies have
    the power to deliver the right message in the right channel at the
    right time for an improved customer experience. Veeva Andi used with
    Customer Journeys—a new capability in Veeva CRM to better target and
    manage customers through stages of an adoption lifecycle—helps
    companies drive the best actions at the right customer stage. Veeva
    Andi is available today in North America. Read today’s Veeva
    Andi press release
    to learn more.
  • Veeva CRM Approved Notes leverages AI to help field reps
    build better customer relationships and remain compliant with every
    interaction. The new capability makes it easy for field reps to
    capture free text notes in Veeva CRM and use the power of AI to detect
    potential compliance risks such as off-label messaging. Veeva CRM
    Approved Notes is included Veeva CRM and planned for availability in
  • Veeva Vault Auto Claims Linking is a new capability in
    Veeva Vault PromoMats that will help improve speed and compliance of
    content development. Vault Auto Claims Linking uses AI to suggest
    links from claims to related references, reducing the administrative
    burden and risk of managing claims across countries, channels, and
    assets. Vault Auto Claims Linking is planned for availability by the
    end of 2019.

In other news today, Veeva introduced new innovations in Veeva CRM,
including Veeva Approved Messaging, to advance compliance and digital
engagement in the life sciences industry. Read today’s Veeva
CRM press release
to learn more.

To learn how Veeva Commercial Cloud enables intelligent customer
engagement, visit

Additional Information

Connect with Veeva on LinkedIn:
@veevasystems on Twitter:
Veeva on Facebook:

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,

Forward-looking Statements

This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2019. This is available on the
company’s website at under
the Investors section and on the SEC’s website at
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to